China's Essential Drug Prices Less Severe Than Expected; Some Prices See Increases
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's National Development and Reform Commission issued Oct. 2 a guideline price for its Essential Drug List, which stipulates price ceilings for 296 drugs on the first part of the list
You may also be interested in...
Dance With Domestic Companies: Pfizer And Merck Look To Broaden Market Access In China Via JVs
Merck/Simcere, Pfizer/Hisun launched JVs in China this week to increase sales in outlying cities.
Dance With Domestic Companies: Pfizer And Merck Look To Broaden Market Access In China Via JVs
Merck/Simcere, Pfizer/Hisun launched JVs in China this week to increase sales in outlying cities.
Merck And Simcere Trial Partnership In China: Two Different Cultures But One Common Goal
NANJING, China - A few weeks after Merck & Co.'s China affiliate MSD and one of China's leading drug makers Simcere Pharmaceutical Group announced a new joint venture to expand access to critical lifestyle drugs across China, the two companies unveiled more details to their innovative partnership